NEU 1.03% $19.30 neuren pharmaceuticals limited

Ann: Neuren completes enrolment in INTREPID clinical trial, page-5

  1. 568 Posts.
    Well done NEU. This is a great milestone as patient recruitment is (way) more than half the battle.

    Not a holder but quietly watching from the side.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.